List of Tables
Table 1. Global Eosinophilic Disease Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Eosinophilic Disease Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Eosinophilic Disease Market Competitive Situation by Manufacturers in 2024
Table 4. Global Eosinophilic Disease Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Eosinophilic Disease Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Eosinophilic Disease Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Eosinophilic Disease Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Eosinophilic Disease Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Eosinophilic Disease, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Eosinophilic Disease, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Eosinophilic Disease, Product Type & Application
Table 12. Global Key Manufacturers of Eosinophilic Disease, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Eosinophilic Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Disease as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Eosinophilic Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Eosinophilic Disease Sales by Region (2020-2025) & (K Units)
Table 18. Global Eosinophilic Disease Sales Market Share by Region (2020-2025)
Table 19. Global Eosinophilic Disease Sales by Region (2026-2031) & (K Units)
Table 20. Global Eosinophilic Disease Sales Market Share by Region (2026-2031)
Table 21. Global Eosinophilic Disease Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Eosinophilic Disease Revenue Market Share by Region (2020-2025)
Table 23. Global Eosinophilic Disease Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Eosinophilic Disease Revenue Market Share by Region (2026-2031)
Table 25. North America Eosinophilic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Eosinophilic Disease Sales by Country (2020-2025) & (K Units)
Table 27. North America Eosinophilic Disease Sales by Country (2026-2031) & (K Units)
Table 28. North America Eosinophilic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Eosinophilic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Eosinophilic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Eosinophilic Disease Sales by Country (2020-2025) & (K Units)
Table 32. Europe Eosinophilic Disease Sales by Country (2026-2031) & (K Units)
Table 33. Europe Eosinophilic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Eosinophilic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Eosinophilic Disease Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Eosinophilic Disease Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Eosinophilic Disease Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Eosinophilic Disease Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Eosinophilic Disease Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Eosinophilic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Eosinophilic Disease Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Eosinophilic Disease Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Eosinophilic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Eosinophilic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Eosinophilic Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Eosinophilic Disease Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Eosinophilic Disease Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Eosinophilic Disease Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Eosinophilic Disease Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Eosinophilic Disease Sales (K Units) by Type (2020-2025)
Table 51. Global Eosinophilic Disease Sales (K Units) by Type (2026-2031)
Table 52. Global Eosinophilic Disease Sales Market Share by Type (2020-2025)
Table 53. Global Eosinophilic Disease Sales Market Share by Type (2026-2031)
Table 54. Global Eosinophilic Disease Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Eosinophilic Disease Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Eosinophilic Disease Revenue Market Share by Type (2020-2025)
Table 57. Global Eosinophilic Disease Revenue Market Share by Type (2026-2031)
Table 58. Global Eosinophilic Disease Price (US$/Unit) by Type (2020-2025)
Table 59. Global Eosinophilic Disease Price (US$/Unit) by Type (2026-2031)
Table 60. Global Eosinophilic Disease Sales (K Units) by Application (2020-2025)
Table 61. Global Eosinophilic Disease Sales (K Units) by Application (2026-2031)
Table 62. Global Eosinophilic Disease Sales Market Share by Application (2020-2025)
Table 63. Global Eosinophilic Disease Sales Market Share by Application (2026-2031)
Table 64. Global Eosinophilic Disease Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Eosinophilic Disease Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Eosinophilic Disease Revenue Market Share by Application (2020-2025)
Table 67. Global Eosinophilic Disease Revenue Market Share by Application (2026-2031)
Table 68. Global Eosinophilic Disease Price (US$/Unit) by Application (2020-2025)
Table 69. Global Eosinophilic Disease Price (US$/Unit) by Application (2026-2031)
Table 70. Takeda Pharmaceutical Company Limited Company Information
Table 71. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 72. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Pharmaceutical Company Limited Eosinophilic Disease Product
Table 74. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 75. Ellodi Pharmaceuticals Company Information
Table 76. Ellodi Pharmaceuticals Description and Business Overview
Table 77. Ellodi Pharmaceuticals Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Ellodi Pharmaceuticals Eosinophilic Disease Product
Table 79. Ellodi Pharmaceuticals Recent Developments/Updates
Table 80. Bristol-Myers Squibb Company Company Information
Table 81. Bristol-Myers Squibb Company Description and Business Overview
Table 82. Bristol-Myers Squibb Company Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Company Eosinophilic Disease Product
Table 84. Bristol-Myers Squibb Company Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Eosinophilic Disease Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. GSK plc Company Information
Table 91. GSK plc Description and Business Overview
Table 92. GSK plc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GSK plc Eosinophilic Disease Product
Table 94. GSK plc Recent Developments/Updates
Table 95. Regeneron Pharmaceuticals Inc Company Information
Table 96. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 97. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Regeneron Pharmaceuticals Inc Eosinophilic Disease Product
Table 99. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 100. Allakos Inc Company Information
Table 101. Allakos Inc Description and Business Overview
Table 102. Allakos Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Allakos Inc Eosinophilic Disease Product
Table 104. Allakos Inc Recent Developments/Updates
Table 105. Arena Pharmaceuticals Ltd Company Information
Table 106. Arena Pharmaceuticals Ltd Description and Business Overview
Table 107. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Arena Pharmaceuticals Ltd Eosinophilic Disease Product
Table 109. Arena Pharmaceuticals Ltd Recent Developments/Updates
Table 110. Revolo Biotherapeutics Company Information
Table 111. Revolo Biotherapeutics Description and Business Overview
Table 112. Revolo Biotherapeutics Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Revolo Biotherapeutics Eosinophilic Disease Product
Table 114. Revolo Biotherapeutics Recent Developments/Updates
Table 115. DBV Technologies Company Information
Table 116. DBV Technologies Description and Business Overview
Table 117. DBV Technologies Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. DBV Technologies Eosinophilic Disease Product
Table 119. DBV Technologies Recent Developments/Updates
Table 120. Cipla Inc Company Information
Table 121. Cipla Inc Description and Business Overview
Table 122. Cipla Inc Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Cipla Inc Eosinophilic Disease Product
Table 124. Cipla Inc Recent Developments/Updates
Table 125. Sun Pharmaceutical Industries Ltd Company Information
Table 126. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 127. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product
Table 129. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Eosinophilic Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sanofi Eosinophilic Disease Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Eosinophilic Disease Distributors List
Table 138. Eosinophilic Disease Customers List
Table 139. Eosinophilic Disease Market Trends
Table 140. Eosinophilic Disease Market Drivers
Table 141. Eosinophilic Disease Market Challenges
Table 142. Eosinophilic Disease Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Eosinophilic Disease
Figure 2. Global Eosinophilic Disease Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Eosinophilic Disease Market Share by Type: 2024 & 2031
Figure 4. Corticosteroids Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Anti-cytokine Drug Product Picture
Figure 7. Cytotoxic Drug Product Picture
Figure 8. Global Eosinophilic Disease Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Eosinophilic Disease Market Share by Application: 2024 & 2031
Figure 10. Eosinophilic Esophagitis
Figure 11. Eosinophilic Granulomatosis with Polyangiitis
Figure 12. Hyper-eosinophilic Syndrome
Figure 13. Nasal Polyposis
Figure 14. Other
Figure 15. Global Eosinophilic Disease Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Eosinophilic Disease Market Size (2020-2031) & (US$ Million)
Figure 17. Global Eosinophilic Disease Sales (2020-2031) & (K Units)
Figure 18. Global Eosinophilic Disease Average Price (US$/Unit) & (2020-2031)
Figure 19. Eosinophilic Disease Report Years Considered
Figure 20. Eosinophilic Disease Sales Share by Manufacturers in 2024
Figure 21. Global Eosinophilic Disease Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Eosinophilic Disease Players: Market Share by Revenue in Eosinophilic Disease in 2024
Figure 23. Eosinophilic Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Eosinophilic Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Eosinophilic Disease Sales Market Share by Country (2020-2031)
Figure 26. North America Eosinophilic Disease Revenue Market Share by Country (2020-2031)
Figure 27. United States Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Eosinophilic Disease Sales Market Share by Country (2020-2031)
Figure 30. Europe Eosinophilic Disease Revenue Market Share by Country (2020-2031)
Figure 31. Germany Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Eosinophilic Disease Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Eosinophilic Disease Revenue Market Share by Region (2020-2031)
Figure 38. China Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Eosinophilic Disease Sales Market Share by Country (2020-2031)
Figure 46. Latin America Eosinophilic Disease Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Eosinophilic Disease Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Eosinophilic Disease Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Eosinophilic Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Eosinophilic Disease by Type (2020-2031)
Figure 56. Global Revenue Market Share of Eosinophilic Disease by Type (2020-2031)
Figure 57. Global Eosinophilic Disease Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Eosinophilic Disease by Application (2020-2031)
Figure 59. Global Revenue Market Share of Eosinophilic Disease by Application (2020-2031)
Figure 60. Global Eosinophilic Disease Price (US$/Unit) by Application (2020-2031)
Figure 61. Eosinophilic Disease Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
